| Derailed estrogen signaling and breast cancer: an authentic couple B Manavathi, O Dey, VNR Gajulapalli, RS Bhatia, S Bugide, R Kumar Endocrine reviews 34 (1), 1-32, 2013 | 153 | 2013 |
| Inhibition of Enhancer of zeste homolog 2 (EZH2) induces natural killer cell-mediated eradication of hepatocellular carcinoma cells S Bugide, MR Green, N Wajapeyee Proceedings of the National Academy of Sciences 115 (15), E3509-E3518, 2018 | 126 | 2018 |
| Hematopoietic PBX-interacting protein (HPIP) is over expressed in breast infiltrative ductal carcinoma and regulates cell adhesion and migration through modulation of focal … S Bugide, D David, A Nair, N Kannan, VSK Samanthapudi, J Prabhakar, ... Oncogene 34 (35), 4601-4612, 2015 | 65 | 2015 |
| HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation S Bugide, VK Gonugunta, V Penugurti, VL Malisetty, RK Vadlamudi, ... Cellular oncology 40, 133-144, 2017 | 62 | 2017 |
| KLF7 promotes pancreatic cancer growth and metastasis by up-regulating ISG expression and maintaining Golgi complex integrity R Gupta, P Malvi, KR Parajuli, R Janostiak, S Bugide, G Cai, LJ Zhu, ... Proceedings of the National Academy of Sciences 117 (22), 12341-12351, 2020 | 55 | 2020 |
| Functional regulation of pre-B-cell leukemia homeobox interacting protein 1 (PBXIP1/HPIP) in erythroid differentiation B Manavathi, D Lo, S Bugide, O Dey, S Imren, MJ Weiss, RK Humphries Journal of Biological Chemistry 287 (8), 5600-5614, 2012 | 49 | 2012 |
| EZH2 inhibits NK cell–mediated antitumor immunity by suppressing CXCL10 expression in an HDAC10-dependent manner S Bugide, R Gupta, MR Green, N Wajapeyee Proceedings of the National Academy of Sciences 118 (30), e2102718118, 2021 | 46 | 2021 |
| Loss of BOP1 confers resistance to BRAF kinase inhibitors in melanoma by activating MAP kinase pathway R Gupta, S Bugide, B Wang, MR Green, DB Johnson, N Wajapeyee Proceedings of the National Academy of Sciences 116 (10), 4583-4591, 2019 | 46 | 2019 |
| PSPH promotes melanoma growth and metastasis by metabolic deregulation-mediated transcriptional activation of NR4A1 V Rawat, P Malvi, D Della Manna, ES Yang, S Bugide, X Zhang, R Gupta, ... Oncogene 40 (13), 2448-2462, 2021 | 28 | 2021 |
| Epigenetic mechanisms dictating eradication of cancer by natural killer cells S Bugide, R Janostiak, N Wajapeyee Trends in cancer 4 (8), 553-566, 2018 | 27 | 2018 |
| Loss of HAT1 expression confers BRAFV600E inhibitor resistance to melanoma cells by activating MAPK signaling via IGF1R S Bugide, KR Parajuli, S Chava, R Pattanayak, DLD Manna, D Shrestha, ... Oncogenesis 9 (5), 44, 2020 | 23 | 2020 |
| Disruptor of telomeric silencing 1-like promotes ovarian cancer tumor growth by stimulating pro-tumorigenic metabolic pathways and blocking apoptosis S Chava, S Bugide, YJK Edwards, R Gupta Oncogenesis 10 (7), 48, 2021 | 16 | 2021 |
| Measurement of natural killer cell-mediated cytotoxicity and migration in the context of hepatic tumor cells S Chava, S Bugide, R Gupta, N Wajapeyee JoVE (Journal of Visualized Experiments), e60714, 2020 | 11 | 2020 |
| CBX5 loss drives EGFR inhibitor resistance and results in therapeutically actionable vulnerabilities in lung cancer S Bugide, YJK Edwards, R Gupta, MR Green, N Wajapeyee Proceedings of the National Academy of Sciences 120 (4), e2218118120, 2023 | 8 | 2023 |
| Betacellulin promotes tumor development and EGFR mutant lung cancer growth by stimulating the EGFR pathway and suppressing apoptosis S Chava, S Bugide, X Zhang, R Gupta, N Wajapeyee Iscience 25 (5), 2022 | 6 | 2022 |
| UBE2T promotes breast cancer tumor growth by suppressing DNA replication stress R Dutta, P Guruvaiah, KK Reddi, S Bugide, DS Reddy Bandi, ... NAR cancer 4 (4), zcac035, 2022 | 5 | 2022 |
| HPIP and RUFY3 are noncanonical guanine nucleotide exchange factors of Rab5 to regulate endocytosis-coupled focal adhesion turnover SS Khumukcham, V Penugurti, S Bugide, A Dwivedi, A Kumari, ... Journal of Biological Chemistry 299 (11), 2023 | 1 | 2023 |
| Co-targeting of specific epigenetic regulators in combination with CDC7 potently inhibit melanoma growth S Chava, S Bugide, P Malvi, R Gupta Iscience 25 (8), 2022 | 1 | 2022 |
| Engagement, reception and breakup: Three steps of cell motility regulated by HPIP signaling S Bugide, B Manavathi Can Cell Microenviron 2, e660, 2015 | 1 | 2015 |
| ALK inhibitors suppress HCC and synergize with anti-PD-1 therapy and ABT-263 in preclinical models S Bugide, DS Reddy, P Malvi, R Gupta, N Wajapeyee Iscience 27 (5), 2024 | | 2024 |
